1.
干预组和对照组临床基线特征的比较
Comparison of baseline characteristics of patients between intervention and control groups
| Characteristic | Intervention | Control | P |
| APACHE: Acute physiology and chronic health evaluation; SOFA: Sequential organ failure assessment. | |||
| Number of patients (n) | 16 | 18 | > 0.05 |
| Gender (male/female) | 11/5 | 11/7 | > 0.05 |
| Age (year) | 52.8±4.8 | 55.5±3.3 | > 0.05 |
| APACHE Ⅱ score | 19.4±1.3 | 22.0±1.2 | > 0.05 |
| SOFA score | 9.8±1.1 | 10.6±0.9 | > 0.05 |
| Onset to recruit duration (day) | 6.2±1.9 | 7.6±1.3 | > 0.05 |
| Diagnosis | |||
| Abdominal infection (n, %) | 5 (31.3) | 6 (33.3) | > 0.05 |
| Non-abdominal infection (n, %) | 11 (68.7) | 12 (66.7) | > 0.05 |
| Comorbidities (n, %) | 11 (68.7) | 14 (77.8) | > 0.05 |
| Hypertension | 2 (12.5) | 3 (16.7) | |
| Diabetics | 1 (6.3) | 4 (22.2) | |
| Respiratory disease | 1 (6.3) | 3 (16.7) | |
| Digestive disease | 1 (6.3) | 1 (5.6) | |
| Cardiac disease | 2 (12.5) | 1 (5.6) | |
| Kidney disease | 2 (12.5) | 1 (5.6) | |
| Immune disorder | 3 (18.8) | 1 (5.6) | |
| Others | 1 (6.3) | 2 (11.1) | |
| Pain and sedative drugs (n, %) | 16 (100) | 18 (100) | > 0.05 |
| Opioids | 13 | 14 | |
| Benzodiazepines | 11 | 10 | |
| Propofol | 7 | 11 | |
| Muscle relaxants | 1 | 1 | |